ADMA
HEALTHCAREADMA Biologics Inc
AI Insight
What's Moving ADMA Today?
No stock-specific AI insight has been generated for ADMA yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.21$20.46
$8.69
Fundamentals
Market Cap$2.0B
P/E Ratio12.6
EPS$0.68
Dividend Yield—
Dividend / Share—
ROE43.3%
Profit Margin32.4%
Debt / Equity—
Trading
Volume3.0M
Avg Volume (10D)—
Shares Outstanding231.8M
ADMA News
46 articles- Join Class Action to Recover Losses From ADMA Biologics, Inc. (ADMA) - Contact Levi & Korsinsky Before August 10, 2026ACCESS Newswire·Jun 23, 2026
- 3 Biotech Firms With Major Potential Catalysts in the Coming MonthsMarketbeat·Jun 21, 2026
- Reminder for ADMA Biologics Securities Class ActionIntellectia AI·Jun 21, 2026
- ADMA Biologics (ADMA) Hit With Federal Securities Lawsuit Over Revenue Inflation AllegationsYahoo Finance·Jun 20, 2026
- ADMA Shareholder Alert: August 10, 2026 Lead Plaintiff Deadline in ADMA Biologics, Inc. ...Caledonian Record·Jun 19, 2026
- ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with the Schall Law FirmGlobeNewswire·Jun 19, 2026
- INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines - ADMAPR Newswire·Jun 18, 2026
- Adma Biologics (ADMA) Dips More Than Broader Market: What You Should KnowYahoo Finance·Jun 17, 2026
- Deadline Approaching: ADMA Biologics, Inc. (ADMA) Shareholders Who Lost Money Urged To Contact Law Offices of Howard G. SmithBenzinga·Jun 15, 2026
- ADMA INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that ADMA Biologics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitBusiness Wire·Jun 13, 2026
- EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of ADMA Biologics, Inc. Investors – ADMABusiness Wire·Jun 11, 2026
- INVESTOR ALERT: Securities Class Action Filed Against ADMA Biologics, Inc. – Investors Encouraged to Contact Kirby McInerney LLPBusiness Wire·Jun 11, 2026
- Adma Biologics (ADMA) Stock Dips While Market Gains: Key FactsYahoo Finance·Jun 11, 2026
- Adma Biologics (ADMA) Down 5.8% Since Last Earnings Report: Can It Rebound?Yahoo Finance·Jun 5, 2026
- US High Growth Tech Stocks with Promising PotentialYahoo Finance·Jun 5, 2026
- New Strong Sell Stocks for June 3rdYahoo Finance·Jun 3, 2026
- ADMA Investor News: If You Have Suffered Losses in ADMAGlobeNewswire·Jun 2, 2026
- ADMA Biologics (ADMA) Valuation After 2026 Guidance Reset And BIVIGAM HeadwindsYahoo Finance·Jun 1, 2026
- ADMA Biologics (ADMA) Receives FDA Label Expansion for ASCENIVYahoo Finance·Jun 1, 2026
- Is ADMA Biologics, Inc. (ADMA) Among the Best Russell 2000 Stocks to Invest In According to Hedge Funds?Yahoo Finance·Jun 1, 2026
- ADMA vs Intellia Therapeutics: Which Biotech Stock Is a Better Pick Now?Yahoo Finance·May 27, 2026
- Can Asceniv Help ADMA Navigate the Current IG Market Challenges?Yahoo Finance·May 26, 2026
- Why a $5 Million New Position Signals Confidence in This Epilepsy Drug PipelineMotley Fool·May 21, 2026
- Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a YearMotley Fool·May 21, 2026
- Is it Time to Exit ADMA Biologics Stock After a 22% Monthly Plunge?Yahoo Finance·May 19, 2026
- How Channel Stuffing Probes and ASCENIV’s Pediatric Expansion Will Impact ADMA Biologics (ADMA) InvestorsYahoo Finance·May 15, 2026
- Here’s What Analysts Think About ADMA Biologics (ADMA)Yahoo Finance·May 14, 2026
- Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic?Yahoo Finance·May 14, 2026
- Adma biologics director Jerrold Grossman buys $100,125 in stockInvesting.com·May 14, 2026
- New Strong Sell Stocks for May 14thYahoo Finance·May 14, 2026
- Adma Biologics director buys $100,125 of common stockInvesting.com·May 12, 2026
- Canaccord Cuts PT on ADMA Biologics Inc. (ADMA) But Remains a Buy on SharesYahoo Finance·May 12, 2026
- $ADMA Investigation Reminder: ADMA Biologics Investigation on behalf of Investors is Ongoing – Contact BFA Law if You Lost MoneyGlobeNewswire·May 11, 2026
- Earnings Flash (ADMA) ADMA Biologics, Inc. Reports Q1 Revenue $114.5M, vs. FactSet Est of $140.0Mmarketscreener.com·May 7, 2026
- INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMAGlobeNewswire Inc.·Apr 28, 2026
- ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc.·Apr 27, 2026
- ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Lufax Holding Ltd Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - LUGlobeNewswire Inc.·Apr 24, 2026
- ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc.·Apr 24, 2026
- ADMA Biologics Investor News: If You Have Suffered Losses in ADMA Biologics, Inc. (NASDAQ: ADMA), You Are Encouraged to Contact The Rosen Law Firm About Your RightsGlobeNewswire Inc.·Apr 18, 2026
- ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.GlobeNewswire Inc.·Apr 10, 2026
Price Data
Open$8.70
Previous Close$8.57
Day High$8.79
Day Low$8.48
52 Week High$20.46
52 Week Low$7.21
52-Week Range
$7.21$20.46
$8.69
Fundamentals
Market Cap$2.0B
P/E Ratio12.6
EPS$0.68
Dividend Yield—
Dividend / Share—
ROE43.3%
Profit Margin32.4%
Debt / Equity—
Trading
Volume3.0M
Avg Volume (10D)—
Shares Outstanding231.8M
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—